Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rayaldee vs Comparators in SHPT and CKD
NCT03588884Phase 4Completed
- Sponsor
- OPKO Health
- Start
- Jun 2018
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of calcifediol in secondary hyperparathyroidism (SHPT), Vitamin D deficiency (VDD), sponsored by OPKO Health. Started Jun 2018; status: completed.
02
Drugs
calcifediol
03
Conditions
secondary hyperparathyroidism (SHPT)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03588884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03588884.